{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:01:58Z","timestamp":1776474118507,"version":"3.51.2"},"reference-count":10,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":872,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1111\/dth.12002","type":"journal-article","created":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T14:26:47Z","timestamp":1365776807000},"page":"370-372","source":"Crossref","is-referenced-by-count":26,"title":["Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab"],"prefix":"10.1155","volume":"26","author":[{"given":"Thivi","family":"Maruthappu","sequence":"first","affiliation":[{"name":"Department of Dermatology; University College London Hospital; London; UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Leandro","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University College London Hospital; London; UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susie D.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University College London Hospital; London; UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2013,4,12]]},"reference":[{"key":"10.1111\/dth.12002-BIB0001|dth12002-cit-0001","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"Autoimmune diseases induced by biological agents, a double edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1111\/dth.12002-BIB0002|dth12002-cit-0002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/03009740902922612","article-title":"Immune mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors","volume":"38","author":"Exarchou","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/dth.12002-BIB0003|dth12002-cit-0003","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1468-3083.2010.03770.x","article-title":"Alopecia areata as another immune-mediated disease developed in patients treated with TNF alpha blocker agents","volume":"25","author":"Ferran","year":"2011","journal-title":"J European Acad Dermatol Venereol"},{"key":"10.1111\/dth.12002-BIB0004|dth12002-cit-0004","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","article-title":"Autoimmunity as an aetiological factor in vitiligo","volume":"21","author":"Rezeal","year":"2007","journal-title":"J European Acad Dermatol Venerol"},{"key":"10.1111\/dth.12002-BIB0005|dth12002-cit-0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/dth.12002-BIB0006|dth12002-cit-0006","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-4632.2006.02744.x","article-title":"Increased TNF alpha and interleukin 1 alpha levels in the lesional skin of patients with nonsegmental viltiligo","volume":"45","author":"Birol","year":"2006","journal-title":"Intern J Dermat."},{"issue":"3","key":"10.1111\/dth.12002-BIB0007|dth12002-cit-0007","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000112932","article-title":"Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab","volume":"216","author":"Simon","year":"2008","journal-title":"Dermatology"},{"key":"10.1111\/dth.12002-BIB0008|dth12002-cit-0008","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2796.2003.01298.x","article-title":"Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor alpha antibodies","volume":"255","author":"D'Auria","year":"2004","journal-title":"J. Internal Medicine"},{"key":"10.1111\/dth.12002-BIB0009|dth12002-cit-0009","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.4049\/jimmunol.167.12.6821","article-title":"In vivo neutoralization of TNF alpha promotes humoral autoimmunity by preventing the induction of CTL","volume":"167","author":"Via","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/dth.12002-BIB0010|dth12002-cit-0010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.61.4.358","article-title":"Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections","volume":"61","author":"Ferraccioli","year":"2002","journal-title":"Ann Rheum Dis"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12002","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12002\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:00:25Z","timestamp":1671818425000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12002"}},"subtitle":["Deterioration of vitiligo"],"short-title":[],"issued":{"date-parts":[[2013,4,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12002","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,12]]}}}